Almost 20 biopharma and life sciences companies have registered to lobby on a bill that could ban US companies from working with Chinese life sciences contractors, according to federal records.
Since the Biosecure Act was introduced in January, most healthcare companies have steered away from publicly commenting on it. But…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
